| Year |
Citation |
Score |
| 2024 |
Gibert MK, Zhang Y, Saha S, Marcinkiewicz P, Dube C, Hudson K, Sun Y, Bednarek S, Chagari B, Sarkar A, Roig-Laboy C, Neace N, Saoud K, Setiady I, Hanif F, ... ... Abounader R, et al. A first comprehensive analysis of Transcribed Ultra Conserved Regions uncovers important regulatory functions of novel non-coding transcripts in gliomas. Research Square. PMID 38699302 DOI: 10.21203/rs.3.rs-4164642/v1 |
0.304 |
|
| 2024 |
Gibert MK, Zhang Y, Saha S, Marcinkiewicz P, Dube C, Hudson K, Sun Y, Bednarek S, Chagari B, Sarkar A, Roig-Laboy C, Neace N, Saoud K, Setiady I, Hanif F, ... ... Abounader R, et al. A first comprehensive analysis of Transcribed Ultra Conserved Regions uncovers important regulatory functions of novel non-coding transcripts in gliomas. Biorxiv : the Preprint Server For Biology. PMID 38562826 DOI: 10.1101/2023.09.12.557444 |
0.304 |
|
| 2023 |
Hanif F, Zhang Y, Dube C, Gibert MK, Saha S, Hudson K, Marcinkiewicz P, Kefas B, Guessous F, Abounader R. miR-3174 Is a New Tumor Suppressor MicroRNA That Inhibits Several Tumor-Promoting Genes in Glioblastoma. International Journal of Molecular Sciences. 24. PMID 37298284 DOI: 10.3390/ijms24119326 |
0.321 |
|
| 2022 |
Mulcahy EQX, Zhang Y, Colόn RR, Cain SR, Gibert MK, Dube CJ, Hafner M, Abounader R. MicroRNA 3928 Suppresses Glioblastoma through Downregulation of Several Oncogenes and Upregulation of p53. International Journal of Molecular Sciences. 23. PMID 35409289 DOI: 10.3390/ijms23073930 |
0.315 |
|
| 2020 |
Mulcahy EQX, Colόn RR, Abounader R. HGF/MET Signaling in Malignant Brain Tumors. International Journal of Molecular Sciences. 21. PMID 33066121 DOI: 10.3390/ijms21207546 |
0.367 |
|
| 2020 |
Xie Z, Janczyk PŁ, Zhang Y, Liu A, Shi X, Singh S, Facemire L, Kubow K, Li Z, Jia Y, Schafer D, Mandell JW, Abounader R, Li H. A cytoskeleton regulator AVIL drives tumorigenesis in glioblastoma. Nature Communications. 11: 3457. PMID 32651364 DOI: 10.1038/S41467-020-17279-1 |
0.417 |
|
| 2019 |
Jung J, Zhang Y, Celiku O, Zhang W, Song H, Williams BJ, Giles AJ, Rich JN, Abounader R, Gilbert MR, Park DM. Mitochondrial NIX Promotes Tumor Survival in the Hypoxic Niche of Glioblastoma. Cancer Research. PMID 31488423 DOI: 10.1158/0008-5472.Can-19-0198 |
0.395 |
|
| 2019 |
Yang Y, Dodbele S, Park T, Glass R, Bhat K, Sulman EP, Zhang Y, Abounader R. MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway. Journal of Neuro-Oncology. PMID 31482267 DOI: 10.1007/S11060-019-03275-Z |
0.41 |
|
| 2019 |
Ngulde SI, Sandabe UK, Abounader R, Dawson TK, Zhang Y, Iliya I, Hussaini IM. Ethanol Extract of Induces Apoptosis in Brain Tumor (U87) Cells. Biomed Research International. 2019: 9826590. PMID 30931334 DOI: 10.1155/2019/9826590 |
0.328 |
|
| 2018 |
Melhuish TA, Kowalczyk I, Manukyan A, Zhang Y, Shah A, Abounader R, Wotton D. Myt1 and Myt1l transcription factors limit proliferation in GBM cells by repressing YAP1 expression. Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms. PMID 30312684 DOI: 10.1016/J.Bbagrm.2018.10.005 |
0.392 |
|
| 2018 |
Cruickshanks N, Zhang Y, Hine S, Gibert M, Yuan F, Oxford M, Grello CM, Pahuski M, Dube C, Guessous F, Wang B, Deveau C, Saoud K, Gallagher RI, Wulfkuhle JD, ... ... Abounader R, et al. Discovery and therapeutic exploitation of mechanisms of resistance to MET inhibitors in glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30201763 DOI: 10.1158/1078-0432.Ccr-18-0926 |
0.355 |
|
| 2018 |
Zhang Y, Dube C, Gibert M, Cruickshanks N, Wang B, Coughlan M, Yang Y, Setiady I, Deveau C, Saoud K, Grello C, Oxford M, Yuan F, Abounader R. The p53 Pathway in Glioblastoma. Cancers. 10. PMID 30200436 DOI: 10.3390/Cancers10090297 |
0.421 |
|
| 2018 |
Olmez I, Zhang Y, Manigat L, Benamar M, Brenneman B, Nakano I, Godlewski J, Bronisz A, Lee J, Abbas T, Abounader R, Purow B. Combined c-Met/Trk inhibition overcomes resistance to CDK4/6 inhibitors in Glioblastoma. Cancer Research. PMID 29844123 DOI: 10.1158/0008-5472.Can-17-3124 |
0.426 |
|
| 2018 |
Gonzalez PP, Kim J, Galvao RP, Cruickshanks N, Abounader R, Zong H. p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression. Glia. PMID 29392777 DOI: 10.1002/Glia.23297 |
0.401 |
|
| 2017 |
Olmez I, Love S, Xiao A, Manigat L, Randolph P, McKenna BD, Neal BP, Boroda S, Li M, Brenneman B, Abounader R, Floyd D, Lee J, Nakano I, Godlewski J, et al. Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha. Neuro-Oncology. PMID 29048560 DOI: 10.1093/Neuonc/Nox119 |
0.319 |
|
| 2017 |
Olmez I, Brenneman B, Xiao A, Serbulea V, Benamar M, Zhang Y, Manigat L, Abbas T, Lee J, Nakano I, Godlewski J, Bronisz A, Abounader R, Leitinger N, Purow B. Combined CDK4/6 and mTOR inhibition is synergistic against glioblastoma via multiple mechanisms. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28814434 DOI: 10.1158/1078-0432.Ccr-17-0803 |
0.414 |
|
| 2017 |
Cruickshanks N, Zhang Y, Yuan F, Pahuski M, Gibert M, Abounader R. Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma. Cancers. 9. PMID 28696366 DOI: 10.3390/Cancers9070087 |
0.465 |
|
| 2017 |
Zhang Y, Cruickshanks N, Yuan F, Wang B, Pahuski M, Wulfkuhle J, Gallagher I, Koeppel AF, Hatef S, Papanicolas C, Lee J, Bar EE, Schiff D, Turner S, Petricoin EF, ... ... Abounader R, et al. Targetable T-type calcium channels drive glioblastoma. Cancer Research. PMID 28512247 DOI: 10.1158/0008-5472.Can-16-2347 |
0.439 |
|
| 2017 |
Guessous F, Cruickshanks NA, Zhang Y, Schiff D, Sarkaria J, Abounader R. Abstract 345: PTEN tumor suppressive effects in glioblastoma are partly mediated by MET downregulation via a p53-miR-34a axis Cancer Research. 77: 345-345. DOI: 10.1158/1538-7445.Am2017-345 |
0.412 |
|
| 2016 |
Reon BJ, Anaya J, Zhang Y, Mandell J, Purow B, Abounader R, Dutta A. Expression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis. Plos Medicine. 13: e1002192. PMID 27923049 DOI: 10.1371/Journal.Pmed.1002192 |
0.359 |
|
| 2016 |
Huse J, Abounader R, Purow B, Hegi M, Soffietti R, Aldape K. Highlights from the Literature. Neuro-Oncology. 18: 1472-1474. PMID 27738179 DOI: 10.1093/Neuonc/Now215 |
0.328 |
|
| 2015 |
Lee DH, Zhang Y, Kassam AB, Park MJ, Gardner P, Prevedello D, Henry S, Horbinski C, Beumer JH, Tawbi H, Williams BJ, Shaffrey ME, Egorin MJ, Abounader R, Park DM. Combined PDGFR and HDAC Inhibition Overcomes PTEN Disruption in Chordoma. Plos One. 10: e0134426. PMID 26247786 DOI: 10.1371/Journal.Pone.0134426 |
0.432 |
|
| 2015 |
Zhang Y, Cruickshanks N, Wulfkuhle J, Gallagher I, Schiff D, Petricoin E, Gray L, Abounader R. Atps-01Inhibition Of T-Type Calcium Channels Sensitizes Glioblastoma Stem Cells To Chemotherapy Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov204.01 |
0.444 |
|
| 2014 |
Awad AJ, Burns TC, Zhang Y, Abounader R. Targeting MET for glioma therapy. Neurosurgical Focus. 37: E10. PMID 25434379 DOI: 10.3171/2014.9.Focus14520 |
0.421 |
|
| 2014 |
Floyd DH, Zhang Y, Dey BK, Kefas B, Breit H, Marks K, Dutta A, Herold-Mende C, Synowitz M, Glass R, Abounader R, Purow BW. Novel anti-apoptotic microRNAs 582-5p and 363 promote human glioblastoma stem cell survival via direct inhibition of caspase 3, caspase 9, and Bim. Plos One. 9: e96239. PMID 24805821 DOI: 10.1371/Journal.Pone.0096239 |
0.43 |
|
| 2014 |
Negishi M, Wongpalee SP, Sarkar S, Park J, Lee KY, Shibata Y, Reon BJ, Abounader R, Suzuki Y, Sugano S, Dutta A. A new lncRNA, APTR, associates with and represses the CDKN1A/p21 promoter by recruiting polycomb proteins. Plos One. 9: e95216. PMID 24748121 DOI: 10.1371/Journal.Pone.0095216 |
0.389 |
|
| 2014 |
Zhang Y, Schiff D, Park D, Abounader R. MicroRNA-608 and microRNA-34a regulate chordoma malignancy by targeting EGFR, Bcl-xL and MET. Plos One. 9: e91546. PMID 24621885 DOI: 10.1371/Journal.Pone.0091546 |
0.4 |
|
| 2014 |
Feng C, Zhang Y, Yin J, Li J, Abounader R, Zuo Z. Regulatory factor X1 is a new tumor suppressive transcription factor that acts via direct downregulation of CD44 in glioblastoma. Neuro-Oncology. 16: 1078-85. PMID 24526308 DOI: 10.1093/Neuonc/Nou010 |
0.323 |
|
| 2014 |
Kim J, Zhang Y, Skalski M, Hayes J, Kefas B, Schiff D, Purow B, Parsons S, Lawler S, Abounader R. microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma. Cancer Research. 74: 1541-53. PMID 24425048 DOI: 10.1158/0008-5472.Can-13-1449 |
0.402 |
|
| 2014 |
Kim J, Zhang Y, Skalski M, Hayes J, Kefas B, Schiff D, Purow B, Parsons S, Lawler S, Abounader R. Abstract 5222: microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma Cancer Research. 74: 5222-5222. DOI: 10.1158/1538-7445.Am2014-5222 |
0.382 |
|
| 2014 |
Zhang Y, Kim J, Mueller AC, Dey B, Yang Y, Lee D, Hachmann J, Finderle S, Park DM, Christensen J, Schiff D, Purow B, Dutta A, Abounader R. Abstract 1909: Identification and characterization of microRNA-134 as a novel receptor tyrosine kinase-regulated tumor suppressive hub in glioblastoma Cancer Research. 74: 1909-1909. DOI: 10.1158/1538-7445.Am2014-1909 |
0.462 |
|
| 2013 |
Kefas B, Floyd DH, Comeau L, Frisbee A, Dominguez C, Dipierro CG, Guessous F, Abounader R, Purow B. A miR-297/hypoxia/DGK-α axis regulating glioblastoma survival. Neuro-Oncology. 15: 1652-63. PMID 24158111 DOI: 10.1093/Neuonc/Not118 |
0.418 |
|
| 2013 |
Kofman AV, Kim J, Park SY, Dupart E, Letson C, Bao Y, Ding K, Chen Q, Schiff D, Larner J, Abounader R. microRNA-34a promotes DNA damage and mitotic catastrophe. Cell Cycle (Georgetown, Tex.). 12: 3500-11. PMID 24091633 DOI: 10.4161/Cc.26459 |
0.357 |
|
| 2013 |
Huang X, Zhang Y, Tang Y, Butler N, Kim J, Guessous F, Schiff D, Mandell J, Abounader R. A novel PTEN/mutant p53/c-Myc/Bcl-XL axis mediates context-dependent oncogenic effects of PTEN with implications for cancer prognosis and therapy. Neoplasia (New York, N.Y.). 15: 952-65. PMID 23908595 DOI: 10.1593/Neo.13376 |
0.427 |
|
| 2013 |
Kofman AV, Letson C, Dupart E, Bao Y, Newcomb WW, Schiff D, Brown J, Abounader R. The p53-microRNA-34a axis regulates cellular entry receptors for tumor-associated human herpes viruses. Medical Hypotheses. 81: 62-7. PMID 23643704 DOI: 10.1016/J.Mehy.2013.04.012 |
0.422 |
|
| 2013 |
Dominguez CL, Floyd DH, Xiao A, Mullins GR, Kefas BA, Xin W, Yacur MN, Abounader R, Lee JK, Wilson GM, Harris TE, Purow BW. Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers. Cancer Discovery. 3: 782-97. PMID 23558954 DOI: 10.1158/2159-8290.Cd-12-0215 |
0.39 |
|
| 2013 |
Zhang Y, Farenholtz KE, Yang Y, Guessous F, Dipierro CG, Calvert VS, Deng J, Schiff D, Xin W, Lee JK, Purow B, Christensen J, Petricoin E, Abounader R. Hepatocyte growth factor sensitizes brain tumors to c-MET kinase inhibition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 1433-44. PMID 23386689 DOI: 10.1158/1078-0432.Ccr-12-2832 |
0.446 |
|
| 2013 |
Guessous F, Alvarado-Velez M, Marcinkiewicz L, Zhang Y, Kim J, Heister S, Kefas B, Godlewski J, Schiff D, Purow B, Abounader R. Oncogenic effects of miR-10b in glioblastoma stem cells. Journal of Neuro-Oncology. 112: 153-63. PMID 23307328 DOI: 10.1007/S11060-013-1047-0 |
0.386 |
|
| 2012 |
Zhang Y, Dutta A, Abounader R. The role of microRNAs in glioma initiation and progression. Frontiers in Bioscience (Landmark Edition). 17: 700-12. PMID 22201769 DOI: 10.2741/3952 |
0.387 |
|
| 2012 |
Guessous F, Yang Y, Johnson E, Marcinkiewicz L, Smith M, Zhang Y, Kofman A, Schiff D, Christensen J, Abounader R. Cooperation between c-Met and focal adhesion kinase family members in medulloblastoma and implications for therapy. Molecular Cancer Therapeutics. 11: 288-97. PMID 22188814 DOI: 10.1158/1535-7163.Mct-11-0490 |
0.416 |
|
| 2012 |
Catania A, Maira F, Skarmoutsou E, D'Amico F, Abounader R, Mazzarino MC. Insight into the role of microRNAs in brain tumors (review) International Journal of Oncology. 40: 605-624. PMID 22179098 DOI: 10.3892/Ijo.2011.1305 |
0.437 |
|
| 2012 |
Kim J, Zhang Y, Guessous F, Abounader R. Abstract 3165: microRNA-148a: A novel oncogenic microRNA in glioblastoma Cancer Research. 72: 3165-3165. DOI: 10.1158/1538-7445.Am2012-3165 |
0.408 |
|
| 2012 |
Kofman A, Guessous F, diPierro CG, Dupart E, Bao Y, Dhamala S, Letson C, Park SY, Marcinkiewicz L, Abounader R. Abstract 3163: Exploration of microRNA-34a effects in human glioma cell lines Cancer Research. 72: 3163-3163. DOI: 10.1158/1538-7445.Am2012-3163 |
0.488 |
|
| 2012 |
Zhang Y, Farenholtz K, Yang Y, Guessous F, Schiff D, Purow B, Christensen J, Abounader R. Abstract 1821: Hepatocyte growth factor sensitizes brain tumor cells and xenografts to c-Met kinase inhibition Cancer Research. 72: 1821-1821. DOI: 10.1158/1538-7445.Am2012-1821 |
0.487 |
|
| 2012 |
Guessous F, Yang Y, Johnson E, Marcinkiewicz L, Smith M, Zhang Y, Kofman A, Schiff D, Christensen J, Abounader R. Abstract 1252: Cooperation between c-Met and focal adhesion kinase pathways in medulloblastoma and implications for therapy Cancer Research. 72: 1252-1252. DOI: 10.1158/1538-7445.Am2012-1252 |
0.462 |
|
| 2011 |
Kofman AV, Abounader R. When tumor cells make blood vessels: implications for glioblastoma therapy. Future Oncology (London, England). 7: 841-3. PMID 21732755 DOI: 10.2217/Fon.11.58 |
0.396 |
|
| 2011 |
Kofman A, Marcinkiewicz L, Dupart E, Lyshchev A, Martynov B, Ryndin A, Kotelevskaya E, Brown J, Schiff D, Abounader R. The roles of viruses in brain tumor initiation and oncomodulation. Journal of Neuro-Oncology. 105: 451-66. PMID 21720806 DOI: 10.1007/S11060-011-0658-6 |
0.401 |
|
| 2011 |
Guessous F, Alvarado M, Zhang Y, Heister S, Kefas B, Schiff D, Abounader R. Abstract 126: Characterization of microRNA-10b in human glioblastoma Cancer Research. 71: 126-126. DOI: 10.1158/1538-7445.Am2011-126 |
0.443 |
|
| 2010 |
Guessous F, Zhang Y, Kofman A, Catania A, Li Y, Schiff D, Purow B, Abounader R. microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle (Georgetown, Tex.). 9: 1031-6. PMID 20190569 DOI: 10.4161/Cc.9.6.10987 |
0.424 |
|
| 2010 |
Guessous F, Zhang Y, diPierro C, Marcinkiewicz L, Sarkaria J, Schiff D, Buchanan S, Abounader R. An orally bioavailable c-Met kinase inhibitor potently inhibits brain tumor malignancy and growth. Anti-Cancer Agents in Medicinal Chemistry. 10: 28-35. PMID 20015006 DOI: 10.2174/1871520611009010028 |
0.49 |
|
| 2010 |
Zhang Y, Farenholtz K, Yang Y, Guessous F, Kofman AV, Christensen J, Abounader R. Abstract 3625: Exogenous short-term activation of c-Met and EGFR sensitizes them to kinase inhibitors Cancer Research. 70: 3625-3625. DOI: 10.1158/1538-7445.Am10-3625 |
0.437 |
|
| 2010 |
Guessous F, Zhang Y, Catania A, Li Y, Kofman A, Kefas B, Schiff D, Purow B, Abounader R. Abstract 2067: Effects of microRNA-34a on brain tumor cells and glioblastoma stem cells Cellular and Molecular Biology. 70: 2067-2067. DOI: 10.1158/1538-7445.Am10-2067 |
0.407 |
|
| 2009 |
Kefas B, Comeau L, Floyd DH, Seleverstov O, Godlewski J, Schmittgen T, Jiang J, diPierro CG, Li Y, Chiocca EA, Lee J, Fine H, Abounader R, Lawler S, Purow B. The neuronal microRNA miR-326 acts in a feedback loop with notch and has therapeutic potential against brain tumors. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 29: 15161-8. PMID 19955368 DOI: 10.1523/Jneurosci.4966-09.2009 |
0.46 |
|
| 2009 |
Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E, Marcinkiewicz L, Jiang J, Yang Y, Schmittgen TD, Lopes B, Schiff D, Purow B, Abounader R. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Research. 69: 7569-76. PMID 19773441 DOI: 10.1158/0008-5472.Can-09-0529 |
0.436 |
|
| 2009 |
Abounader R. Interactions between PTEN and receptor tyrosine kinase pathways and their implications for glioma therapy. Expert Review of Anticancer Therapy. 9: 235-45. PMID 19192961 DOI: 10.1586/14737140.9.2.235 |
0.437 |
|
| 2009 |
Li Y, Guessous F, DiPierro C, Zhang Y, Mudrick T, Fuller L, Johnson E, Marcinkiewicz L, Engelhardt M, Kefas B, Schiff D, Kim J, Abounader R. Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy. Molecular Cancer Therapeutics. 8: 376-85. PMID 19190120 DOI: 10.1158/1535-7163.Mct-08-0627 |
0.47 |
|
| 2008 |
Guessous F, Li Y, Abounader R. Signaling pathways in medulloblastoma. Journal of Cellular Physiology. 217: 577-83. PMID 18651559 DOI: 10.1002/Jcp.21542 |
0.401 |
|
| 2008 |
Kefas B, Godlewski J, Comeau L, Li Y, Abounader R, Hawkinson M, Lee J, Fine H, Chiocca EA, Lawler S, Purow B. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Research. 68: 3566-72. PMID 18483236 DOI: 10.1158/0008-5472.Can-07-6639 |
0.449 |
|
| 2008 |
Li Y, Guessous F, Kwon S, Kumar M, Ibidapo O, Fuller L, Johnson E, Lal B, Hussaini I, Bao Y, Laterra J, Schiff D, Abounader R. PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations. Cancer Research. 68: 1723-31. PMID 18339852 DOI: 10.1158/0008-5472.Can-07-1963 |
0.421 |
|
| 2008 |
Reznik TE, Sang Y, Ma Y, Abounader R, Rosen EM, Xia S, Laterra J. Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor. Molecular Cancer Research : McR. 6: 139-50. PMID 18234969 DOI: 10.1158/1541-7786.Mcr-07-0236 |
0.386 |
|
| 2008 |
Li Y, Guessous F, Johnson EB, Eberhart CG, Li XN, Shu Q, Fan S, Lal B, Laterra J, Schiff D, Abounader R. Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 98-111. PMID 18059365 DOI: 10.1038/Labinvest.3700702 |
0.407 |
|
| 2007 |
Xu J, Gao M, Fan S, Meng Q, Goldberg ID, Abounader R, Ressom H, Laterra JJ, Rosen EM. Effect of Akt inhibition on scatter factor-regulated gene expression in DU-145 human prostate cancer cells. Oncogene. 26: 2925-38. PMID 17099727 DOI: 10.1038/Sj.Onc.1210088 |
0.436 |
|
| 2005 |
Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Cancer Research. 65: 9355-62. PMID 16230398 DOI: 10.1158/0008-5472.Can-05-1946 |
0.5 |
|
| 2005 |
Abounader R, Laterra J. Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis. Neuro-Oncology. 7: 436-51. PMID 16212809 DOI: 10.1215/S1152851705000050 |
0.473 |
|
| 2005 |
Beckner ME, Gobbel GT, Abounader R, Burovic F, Agostino NR, Laterra J, Pollack IF. Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 85: 1457-70. PMID 16170333 DOI: 10.1038/Labinvest.3700355 |
0.387 |
|
| 2005 |
Lal B, Xia S, Abounader R, Laterra J. Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4479-86. PMID 15958633 DOI: 10.1158/1078-0432.Ccr-05-0166 |
0.404 |
|
| 2004 |
Abounader R, Reznik T, Colantuoni C, Martinez-Murillo F, Rosen EM, Laterra J. Regulation of c-Met-dependent gene expression by PTEN. Oncogene. 23: 9173-82. PMID 15516982 DOI: 10.1038/Sj.Onc.1208146 |
0.42 |
|
| 2004 |
Liang H, O'Reilly S, Liu Y, Abounader R, Laterra J, Maher VM, McCormick JJ. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity. International Journal of Oncology. 24: 1057-67. PMID 15067326 DOI: 10.3892/Ijo.24.5.1057 |
0.377 |
|
| 2004 |
Su W, Gutmann DH, Perry A, Abounader R, Laterra J, Sherman LS. CD44-independent hepatocyte growth factor/c-Met autocrine loop promotes malignant peripheral nerve sheath tumor cell invasion in vitro. Glia. 45: 297-306. PMID 14730703 DOI: 10.1002/Glia.10340 |
0.417 |
|
| 2003 |
Herynk MH, Stoeltzing O, Reinmuth N, Parikh NU, Abounader R, Laterra J, Radinsky R, Ellis LM, Gallick GE. Down-regulation of c-Met inhibits growth in the liver of human colorectal carcinoma cells. Cancer Research. 63: 2990-6. PMID 12782608 |
0.326 |
|
| 2002 |
Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM, Laterra J. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 108-10. PMID 11729097 DOI: 10.1096/Fj.01-0421Fje |
0.475 |
|
| 2001 |
Abounader R, Ranganathan S, Kim BYS, Nichols C, Laterra J. Signaling pathways in the induction of c-met receptor expression by its ligand scatter factor/hepatocyte growth factor in human glioblastoma Journal of Neurochemistry. 76: 1497-1508. PMID 11238734 DOI: 10.1046/J.1471-4159.2001.00158.X |
0.419 |
|
| 2000 |
Guerin C, Luddy C, Abounader R, Lal B, Laterra J. Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor. Biochemical and Biophysical Research Communications. 273: 287-93. PMID 10873600 DOI: 10.1006/Bbrc.2000.2935 |
0.401 |
|
| 1999 |
Abounader R, Ranganathan S, Lal B, Fielding K, Book A, Dietz H, Burger P, Laterra J. Reversion of human glioblastoma malignancy by U1 small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression Journal of the National Cancer Institute. 91: 1548-1556. PMID 10491431 DOI: 10.1093/Jnci/91.18.1548 |
0.44 |
|
| 1999 |
Book AA, Ranganathan S, Abounader R, Rosen E, Laterra J. Scatter factor/hepatocyte growth factor gene transfer increases rat blood-glioma barrier permeability Brain Research. 833: 173-180. PMID 10375692 DOI: 10.1016/S0006-8993(99)01527-9 |
0.395 |
|
| Show low-probability matches. |